Abstract:Background: Some studies in humans show that the concurrent use of clopidogrel and omeprazole decreases plasma clopidogrel active metabolite (CAM) concentrations and clopidogrel antiplatelet effects. Whether this drug interaction occurs in cats is unknown. Hypothesis: We hypothesized that administration of clopidogrel with omeprazole would decrease plasma CAM concentrations and decrease clopidogrel antiplatelet effects in healthy cats. Animals: Ten domestic cats. Methods: In this 2-sequence, 2-period, 2-treatment randomized crossover study, healthy cats were randomly assigned to receive clopidogrel only (18.75 mg PO q24h) or clopidogrel with omeprazole (1 mg/kg PO q12h) for 10 days, followed by a 2-week washout period, and then the opposite treatment for another 10 days. Blood was collected by jugular venipuncture on days 0, 5, and 10. Plasma CAM concentrations were measured using high-performance liquid chromatography-tandem mass spectrometry. Platelet function was evaluated using Plateletworks, Multiplate Analyzer, and Platelet Function Analyzer-100 (PFA-100). Results: Multiplate Analyzer and PFA-100 detected no difference in platelet function between days or treatment groups. Plateletworks detected a significant difference (P < .001) in platelet function from day 0 to 5 and day 0 to 10 in both treatment groups but no difference between treatment groups. Plasma CAM concentrations were significantly lower on day 10 (P < .02) in cats receiving both medications versus clopidogrel only. Conclusions and clinical importance: Concurrent omeprazole and clopidogrel administration was associated with altered pharmacokinetics on day 10, but no difference in pharmacodynamics between the 2 treatment groups. The short-term use of clopidogrel and omeprazole does not seem to alter platelet function significantly.

Effects of Omeprazole on Pharmacokinetics of Oxiracetam in Rats

Influence of Oxiracetam on Pharmacokinetics of Omeprazol in Rats

A Randomized Double-Blind Controlled Multicenter Study with Oxiracetam in Treatment of Organic Brain Syndrome

Effect of Omeprazole on the Hydroxylation of Warfarin Enantiomers in Human: In-Vitro Studies with Liver Microsomes and Cdna-Expressed Cytochrome P450 Isozymes

Effect of Omeprazole in treating peptic ulcers of children

Pharmacokinetics of Oxiracetam for Injection in Chinese Healthy Volunteers

Effects of Rabeprazole on Pharmacokinetics of Clopidogrel in Rats

STUDY ON PHARMACOKINETICS OF OMEPRAZOLE CAPSULE IN HEALTHY VOLUNTEERS

UHPLC method for simultaneous assessment of pharmacokinetic parameters of co-administered voriconazole and omeprazole using rat plasma

Pharmacokinetic Comparisons of S-Oxiracetam and R-Oxiracetam in Beagle Dogs

Pharmacokinetics of Omeprazole in Rats with Dextran Sulfate Sodium-Induced Ulcerative Colitis

Clinical Study of Drug-Drug Interaction Between Omeprazole and Pyrotinib after Meal.

Pharmacokinetics and Relative Bioavailability of Omeprazole Capsule in HealthyVolunteers after a Single Oral Administration

Pharmacokinetics and 24-Hour Intragastric Ph Monitoring after Venous Infusion of Omeprazole in Healthy Subjects

Clinical study of oxiracetam for treatment of Alzheimer's disease

Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole.

The Effect of Low-Dose Omeprazole on 24-Hour Intragastric Ph in Healthy Human Subjects

Development and Validation of a Chiral UPLC-MS/MS Method for Quantifying S-Oxiracetam and R-Oxiracetam in Human Plasma, Urine and Feces: Application to a Phase-I Clinical Pharmacokinetic Study

Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS.

The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats

Effect of Cimetidine and Phenobarbital on metabolite kinetics of Omeprazole in rats